BridgeBio Pharma Currently Down Eight Consecutive Days, on Pace for Record Losing Streak -- Data Talk

BridgeBio Pharma, Inc. (BBIO) is currently at $75.11, down $1.49 or 1.95%

--Would be lowest close since July 1, 2026, when it closed at $74.52

--On pace for largest percent decrease since Aug. 28, 2026, when it fell 2.64%

--Currently down eight consecutive days; down 10.53% over this period

--Longest losing streak on record (Based on available data back to June 27, 2019)

--Worst eight day stretch since the eight days ending March 2, 2026, when it fell 11.4%

--Down 6.22% month-to-date; on pace for worst month since May 2026, when it fell 6.82%

--Down 1.8% year-to-date

--Down 16.7% from its all-time closing high of $90.17 on July 9, 2026

--Up 45.11% from 52 weeks ago (Aug. 29, 2025), when it closed at $51.76

--Down 16.7% from its 52-week closing high of $90.17 on July 9, 2026

--Up 53.29% from its 52-week closing low of $49.00 on Sept. 25, 2025

--Traded as low as $75.02; lowest intraday level since July 2, 2026, when it hit $74.49

--Down 2.06% at today's intraday low

All data as of 10:23:22 AM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 31, 2026 10:25 ET (14:25 GMT)